Cargando…

Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial

INTRODUCTION: To alleviate clinical symptoms of diabetic nephropathy (DN), several dietary and non-dietary strategies have been suggested. Probiotic-enriched foods, through their effects on modulating microflora, might help these patients control the adverse effects. The current study will be done t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoreishy, Seyed Mojtaba, Shirzad, Nooshin, Nakhjavani, Manouchehr, Esteghamati, Alireza, Djafarian, Kurosh, Esmaillzadeh, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971794/
https://www.ncbi.nlm.nih.gov/pubmed/35361646
http://dx.doi.org/10.1136/bmjopen-2021-056110
_version_ 1784679711550472192
author Ghoreishy, Seyed Mojtaba
Shirzad, Nooshin
Nakhjavani, Manouchehr
Esteghamati, Alireza
Djafarian, Kurosh
Esmaillzadeh, Ahmad
author_facet Ghoreishy, Seyed Mojtaba
Shirzad, Nooshin
Nakhjavani, Manouchehr
Esteghamati, Alireza
Djafarian, Kurosh
Esmaillzadeh, Ahmad
author_sort Ghoreishy, Seyed Mojtaba
collection PubMed
description INTRODUCTION: To alleviate clinical symptoms of diabetic nephropathy (DN), several dietary and non-dietary strategies have been suggested. Probiotic-enriched foods, through their effects on modulating microflora, might help these patients control the adverse effects. The current study will be done to examine the effects of probiotic yoghurt consumption on albumin to creatinine ratio, estimated glomerular filtration rate (eGFR) and metabolic parameters in patients with type 2 diabetes with nephropathy. METHODS AND ANALYSIS: Sixty patients with DN will be recruited in this study. After block matching for sex, body mass index and age, patients will be randomly assigned to receive 300 g/day probiotic yoghurt containing 10(6) CFU/g Lactobacillus acidophilus and Bifidobacterium lactis strains or 300 g/day plain yoghurt daily for 8 weeks. Weight, height and waist circumference will be measured at study baseline and after the intervention. Biochemical indicators including glycaemic measures (haemoglobin A1c (HbA1c), fasting blood sugar (FBS)), inflammatory markers (high sensitivity-C reactive protein), lipid profile (total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL)) and finally renal makers (creatinine, albumin to creatinine ratio, eGFR) will be assessed at study baseline and at the end of the trial. DISCUSSION: Improving the condition of a person with DN is a serious clinical challenge. The use of probiotic supplements has been considered in these people, but the use of probiotic-enriched foods has received less attention. TRIAL REGISTRATION NUMBER: Iranian Registry of Clinical Trials (www.irct.ir) (IRCT20201125049491N1).
format Online
Article
Text
id pubmed-8971794
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89717942022-04-20 Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial Ghoreishy, Seyed Mojtaba Shirzad, Nooshin Nakhjavani, Manouchehr Esteghamati, Alireza Djafarian, Kurosh Esmaillzadeh, Ahmad BMJ Open Diabetes and Endocrinology INTRODUCTION: To alleviate clinical symptoms of diabetic nephropathy (DN), several dietary and non-dietary strategies have been suggested. Probiotic-enriched foods, through their effects on modulating microflora, might help these patients control the adverse effects. The current study will be done to examine the effects of probiotic yoghurt consumption on albumin to creatinine ratio, estimated glomerular filtration rate (eGFR) and metabolic parameters in patients with type 2 diabetes with nephropathy. METHODS AND ANALYSIS: Sixty patients with DN will be recruited in this study. After block matching for sex, body mass index and age, patients will be randomly assigned to receive 300 g/day probiotic yoghurt containing 10(6) CFU/g Lactobacillus acidophilus and Bifidobacterium lactis strains or 300 g/day plain yoghurt daily for 8 weeks. Weight, height and waist circumference will be measured at study baseline and after the intervention. Biochemical indicators including glycaemic measures (haemoglobin A1c (HbA1c), fasting blood sugar (FBS)), inflammatory markers (high sensitivity-C reactive protein), lipid profile (total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL)) and finally renal makers (creatinine, albumin to creatinine ratio, eGFR) will be assessed at study baseline and at the end of the trial. DISCUSSION: Improving the condition of a person with DN is a serious clinical challenge. The use of probiotic supplements has been considered in these people, but the use of probiotic-enriched foods has received less attention. TRIAL REGISTRATION NUMBER: Iranian Registry of Clinical Trials (www.irct.ir) (IRCT20201125049491N1). BMJ Publishing Group 2022-03-30 /pmc/articles/PMC8971794/ /pubmed/35361646 http://dx.doi.org/10.1136/bmjopen-2021-056110 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
Ghoreishy, Seyed Mojtaba
Shirzad, Nooshin
Nakhjavani, Manouchehr
Esteghamati, Alireza
Djafarian, Kurosh
Esmaillzadeh, Ahmad
Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
title Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
title_full Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
title_fullStr Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
title_full_unstemmed Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
title_short Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
title_sort effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, egfr and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971794/
https://www.ncbi.nlm.nih.gov/pubmed/35361646
http://dx.doi.org/10.1136/bmjopen-2021-056110
work_keys_str_mv AT ghoreishyseyedmojtaba effectofdailyconsumptionofprobioticyoghurtonalbumintocreatinineratioegfrandmetabolicparametersinpatientswithtype2diabeteswithmicroalbuminuriastudyprotocolforarandomisedcontrolledclinicaltrial
AT shirzadnooshin effectofdailyconsumptionofprobioticyoghurtonalbumintocreatinineratioegfrandmetabolicparametersinpatientswithtype2diabeteswithmicroalbuminuriastudyprotocolforarandomisedcontrolledclinicaltrial
AT nakhjavanimanouchehr effectofdailyconsumptionofprobioticyoghurtonalbumintocreatinineratioegfrandmetabolicparametersinpatientswithtype2diabeteswithmicroalbuminuriastudyprotocolforarandomisedcontrolledclinicaltrial
AT esteghamatialireza effectofdailyconsumptionofprobioticyoghurtonalbumintocreatinineratioegfrandmetabolicparametersinpatientswithtype2diabeteswithmicroalbuminuriastudyprotocolforarandomisedcontrolledclinicaltrial
AT djafariankurosh effectofdailyconsumptionofprobioticyoghurtonalbumintocreatinineratioegfrandmetabolicparametersinpatientswithtype2diabeteswithmicroalbuminuriastudyprotocolforarandomisedcontrolledclinicaltrial
AT esmaillzadehahmad effectofdailyconsumptionofprobioticyoghurtonalbumintocreatinineratioegfrandmetabolicparametersinpatientswithtype2diabeteswithmicroalbuminuriastudyprotocolforarandomisedcontrolledclinicaltrial